Connection

Alessandro Rambaldi to Europe

Back to Details
This is a "connection" page, showing publications Alessandro Rambaldi has written about Europe.
Alessandro Rambaldi
Connection Strength
0.136
Europe
  1. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia. 2021 02; 35(2):485-493.
    View in: PubMed
    Score: 0.066
  2. Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. Blood Cancer J. 2021 02 04; 11(2):21.
    View in: PubMed
    Score: 0.016
  3. Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia. Hematology. 2019 Dec; 24(1):337-348.
    View in: PubMed
    Score: 0.015
  4. Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT. Eur J Cancer. 2019 01; 106:212-219.
    View in: PubMed
    Score: 0.014
  5. Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study. Bone Marrow Transplant. 2018 03; 53(3):291-299.
    View in: PubMed
    Score: 0.013
  6. Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population. Leuk Lymphoma. 2016 May; 57(5):1234-7.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.